Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reply: To PMID 11456302

Chris H Polman, Stephen C Reingold, Brian G Weinshenker

    Annals of Neurology
    |April 25, 2006
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Immunity Gone Viral: Subacute Cognitive Decline With Multifocal Brain Lesions in Neuromyelitis Optica Spectrum Disorder.

    Neurology(R) neuroimmunology & neuroinflammation·2026
    Same author

    Identification of genetic risk loci associated with aquaporin 4-positive neuromyelitis optica spectrum disorder: a genome-wide association study.

    The Lancet. Neurology·2026
    Same author

    Critical demyelinating lesions in progressive multiple sclerosis: a prospective observational study.

    Journal of neurology·2025
    Same author

    Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study.

    Neurology(R) neuroimmunology & neuroinflammation·2025
    Same author

    Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study.

    Neurology(R) neuroimmunology & neuroinflammation·2025
    Same author

    Emerging Role of Targeted Monoclonal Antibodies in Neuromyelitis Optica Spectrum Disorders.

    BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2025